HAZLET, N.J. - eTradeWire -- In this symposium, an expert multidisciplinary faculty will provide insights into and interpretations of clinical data, and challenging cases will reinforce key elements of prudent management of major bleeding in patients taking DOACs and experiencing intracranial hemorrhage.

The educational objectives include:

• Interpret clinical evidence with a specific reversal agent targeting dabigatran
• Explain clinical trial data for a specific reversal agent for factor Xa inhibition
• Describe critical considerations in managing the patient experiencing intracranial hemorrhage while receiving a direct oral anticoagulant (DOAC)

Click here for more information

More on eTradeWire News

• A Celebration of American Music Benefit at North Coast Repertory Theatre
• The Human Resilience Project Launches Groundbreaking Global Study on Human Resilience
• Dark Truth Behind Targeted Mass Violence
• Energy Psychology Group Announces Conclusion of Strategic Alliance with Cosmic Media
• Los Defensores Launches "Siempre Contigo" Community Initiative with Philanthropic Grants to Mark the Expansion of Its Local Houston Initiatives

CHAIR
Truman J. Milling, Jr., MD
Professor, Department of Clinical Sciences
Tilman J. Fertitta Family College of Medicine
University of Houston, Houston, Texas
Associate Professor
Departments of Neurology and Surgery and Perioperative Care
Dell Medical School at the University of Texas Austin
Austin, Texas

FACULTY
Anne Alexandrov, PhD, AGACNP-BC, ANVP-BC, CCRN, FAAN
Professor of Nursing and Neurology
The University of Tennessee Health Science Center
Memphis, Tennessee

Paul Dobesh, PharmD
Professor
College of Pharmacy
University of Nebraska Medical Center
Omaha, Nebraska

Joshua Goldstein, MD, PhD
Professor of Emergency Medicine
Harvard Medical School
Endowed Chair in Emergency Medicine Research
Massachusetts General Hospital
Boston, Massachusetts

This educational activity is intended for clinicians managing patients experiencing intracranial hemorrhage.

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.

More on eTradeWire News

• Jazz Artist Bob Holz Signs With SoVibe Entertainment Plus Album Review In September 2024 Issue Of Downbeat Magazine
• CacklePatch, LLC Unveils The Legend of CacklePatch – The Halloween Raccoon
• Prize Draw UK hosts first successful live draw on Facebook
• 2024 Mount Dora Mayoral Forum Candidates Answer the Burning Questions
• 4-Star Gold Coast Hotel Showcases Chicago Artist's Watercolors

Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Voxmedia LLC designates this live activity for a maximum of 1.0 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1.0 Credits™ through its reciprocity agreements. The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.